Prescription Medicines

Roche Australia’s prescription medicines division holds a prominent position in many major therapeutic areas, including obesity, oncology, HIV, cardiovascular, transplantation and kidney disease. We also have a rich development pipeline of innovative products to treat conditions such as breast cancer, colorectal cancer and hepatitis C.

While Roche will continue to hold a strong position as a specialist healthcare provider, it is also playing an important role in the primary care arena, through medicines to treat diseases such as influenza and obesity.

The Roche Group is focused on holding its place on the world pharmaceutical stage as a leading research and development company, in all areas of its business. This means that Roche Australia is looking at a bright future due to this strong development pipeline.

We are committed to taking advantage of new technologies and discoveries to deliver superior quality prescription medicines to our customers.